AIDS Care China (ACC) joined the Alliance in 2013. ACC was founded in 2001 by a group of people living with HIV. ACC now works in five provinces, reaching over 30,000 people annually – about a quarter of all people living with HIV who are on treatment.
China has a low adult prevalence (0.1%) but a large number of people living with HIV (around 740,000). The epidemic disproportionately affects people who inject drugs, sex workers and men who have sex with men. In 2009, 32.5% of new infections in China were among men who have sex with men and 24.3 % were the result of injecting drug use.
Although HIV has been detected in all 31 provinces and municipalities of China, three quarters of people living with HIV are in five provinces, and 90% of infections among injecting drug users are in seven provinces.
There is a general consensus that the national response to HIV has improved dramatically since 2003. The government has increased funding for the response and committed to providing free treatment, care and prevention services. It is expanding its work with injecting drug users, and has taken steps to protect the rights of people living with HIV.
WHAT WE DO
AIDS Care China works in five provinces, reaching over 30,000 people annually, through its Red Ribbon centers in clinics/hospitals. These provide treatment literacy and support to people living with HIV. Their work concentrates on people who use drugs, prisoners and men who have sex with men. They also run three clinics to provide high quality, affordable health care for people living with HIV.
Community Action on Harm Reduction
AIDS Care China is an implementing partner of the Alliance’s ambitious Community Action on Harm Reduction programme (CAHR).
Work focuses on Sichuan province where prevalence of HIV amongst people who inject drugs is 18%. The project will substantially rely upon the peer support programmes to methadone maintenance treatment and introduce such innovative activities as HIV prevention among stimulant users and incorporation of rapid testing into harm reduction package.